Paw Ekta, Ong Chelsea T W, Vangaveti Venkat
James Cook University, College of Medicine and Dentistry, Townsville, Queensland 4811, Australia.
Mater Hospital Pimlico, Department of Surgery, Townsville, Queensland 4812, Australia.
J Surg Case Rep. 2020 Dec 28;2020(12):rjaa528. doi: 10.1093/jscr/rjaa528. eCollection 2020 Dec.
This case is of a 34-year-old immunocompromised male with Pott's puffy tumour, which was treated with antibiotics and endoscopic sinus surgery. Pott's puffy tumour is typically a complication of frontal sinusitis in children and immunocompromise can be a precipitating factor. A search was conducted of Embase, Medline, CINAHL, Cochrane, Google Scholar, Informit and Scopus of 'Pott's Puffy' and variations of this phrase. Initial 804 records were reviewed by title, abstract and full text. Of the unique papers identified, 155 only included paediatric patients and 128 included adult patients. After title, abstract and full-text review of 13 papers were identified describing Pott's puffy tumour in immunocompromised patients. Immunosuppression was noted as a risk factor in only a small number of cases, with diabetes mellitus being the most common. A few cases did note immunosuppression due to newer immunomodulatory agents being used for treatment of autoimmune conditions.
该病例为一名34岁的免疫功能低下男性，患有波特氏浮肿性肿瘤，接受了抗生素和鼻内镜鼻窦手术治疗。波特氏浮肿性肿瘤通常是儿童额窦炎的并发症，免疫功能低下可能是一个诱发因素。我们对Embase、Medline、CINAHL、Cochrane、谷歌学术、Informit和Scopus数据库进行了检索，搜索词为“波特氏浮肿”及其变体。初步检索到804条记录，通过标题、摘要和全文进行了筛选。在筛选出的独特文献中，155篇仅纳入了儿科患者，128篇纳入了成年患者。在对13篇描述免疫功能低下患者波特氏浮肿性肿瘤的文献进行标题、摘要和全文审查后，发现仅有少数病例将免疫抑制作为危险因素，最常见的是糖尿病。少数病例确实提到由于使用新型免疫调节药物治疗自身免疫性疾病而导致免疫抑制。
